Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Teladoc Health Can Move Higher if Short Sellers Get Out of the Way

By Chris Markoch, InvestorPlace Contributor
TDOC stock is trading at levels not seen since the pandemic began. Revenue is up, but so is short interest -- and something has to give.

Post-Pandemic Economics Is a Problem for Opendoor Technologies

By Josh Enomoto, InvestorPlace Contributor
While OPEN stock might be appealing as a tech play, the harsh reality is that the premium tied to its iBuyer model is too steep.

Tilray Stock Should Recover Its Footing in Due Time

By Nicolas Chahine, InvestorPlace Contributor
The business opportunity provided by Tilray is still bright, meanwhile the TLRY stock has already gone through a lifetime of whipsaws.

This Tiny, Little-Known Company Could Explode Along With Electric Car Stocks

By Luke Lango, InvestorPlace Senior Investment Analyst
When gas prices go up, consumers start thinking about all the money they could save with an electric car. The more they think that the more they research EVs, which bodes well for electric car stocks.

What Volatility in Novavax Means for Investors

By Alex Sirois, InvestorPlace Contributor
Novavax continues to await FDA news about its Covid-19 vaccine, but that's not everything that drives the price of NVAX stock.

Decade-High Mortgage Rates Will Put Pressure on Rocket Companies

By David Moadel, InvestorPlace Contributor
You can get exposure to a mortgage-origination giant with RKT stock -- but be cautious as home-buying activity could slow down in 2022.

Rivian’s New CSO Could Help Revive RIVN Stock In the Long Run

By Alex Sirois, InvestorPlace Contributor
Downtrodden RIVN stock needs a shot in the arm and Anisa Kamadoli Costa, a newly appointed CSO by Rivian, could be the trick.

Don’t Buy CLOV Stock Ahead of Earnings Report

By Alex Sirois, InvestorPlace Contributor
CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings.

Forget Twitter, Tesla Is Facing Racial Discrimination and Other Lawsuits

By Alex Sirois, InvestorPlace Contributor
TSLA stock is moving because of Twitter, but Tesla is also losing racially based lawsuits and faces others as well.

The Longer the Wait, The Smaller the Opportunity for Novavax

By Vandita Jadeja
The delay in FDA approval is making the opportunity smaller for Novavax, but the opportunity still remains. NVAX stock is a hold.

3 Hot Stocks That Could Be Set for a Cold Shower

By Tezcan Gecgil, InvestorPlace Contributor
Rising inflation, high energy prices and geopolitical turmoil have become this year's dominating themes. Here are three hot stocks that could see declines in the rest of the year.

Survive a Recession by Capitalizing on This Rare Emerging Market Phenomenon

By Luke Lango, InvestorPlace Senior Investment Analyst
Every time these rare divergences emerge, they become generational buying opportunities, where stock prices boomerang to their fundamental growth trends. Don't miss out...

EV Investors, Go Big or Go Home with Cenntro Electric Stock

By David Moadel, InvestorPlace Contributor
CENN stock holders might have trouble shaking off the memory of Naked Brand, but Cenntro has real potential as an EV market contender.

World’s Largest Money Manager Says Energy Stocks Are Positioned for an ‘Investment Boom’

By Luke Lango, InvestorPlace Senior Investment Analyst
The market is awfully volatile lately. One day, stocks are up big. The next, they plummet. And ultimately, they appear to be going nowhere while inflation and gas prices are roaring higher. Not to mention a war rages on in Europe and China struggles with a new wave of Covid-19 lockdowns.

Novavax: The Party’s Over

By Dana Blankenhorn, InvestorPlace Contributor
Novavax made its vaccine in the traditional way and with an adjuvant to let it cover more people. But people still seem to prefer mRNA vaccines.

7 Earnings Reports to Watch the Week of April 18

By Joel Baglole, InvestorPlace Contributor
Earnings season is back in full swing and big upcoming reports include a major bank, a health company and the king of EV makers.

This Is When You Should Be Worried About SoFi Stock

By Patrick Sanders, InvestorPlace Contributor
SOFI stock is down more than 50% since the beginning of the year, and by 14.4% in the last month. Over the last week, SOFI shed 10%.

Can Tesla Hold up Despite Shanghai Factory Shutdown? 

By Bret Kenwell, InvestorPlace Contributor
TSLA stock is in focus as Elon Musk makes a play for Twitter. However, Tesla should be in focus for other reasons too, besides its CEO.

Moderna May Have Put Its Best Days Behind It

By Chris Markoch, InvestorPlace Contributor
MRNA stock is up 11% in the last 30 days. However, for many reasons, the stock may face resistance as it tries to move higher.
Load More Articles